Turning the tide in myelodysplastic/myeloproliferative neoplasms

Nature Reviews Cancer 17, 425 (2017). doi:10.1038/nrc.2017.40 Authors: Michael W. N. Deininger, Jeffrey W. Tyner & Eric Solary Myelodysplastic syndromes/myeloproliferative neoplasms (MDS/MPN) are aggressive myeloid malignancies recognized as a distinct category owing to their unique combination of dysplastic and proliferative features. Although current classification schemes still emphasize morphology and exclusionary criteria, disease-defining somatic mutations and/or germline predisposition alleles are increasingly incorporated into diagnostic
Source: Nature Reviews Cancer - Category: Cancer & Oncology Authors: Tags: Review Source Type: research